PCAB
PHAT FDA accepts NDA for VOQUEZNA for the treatment of heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD).
PDUFA 07/19/24$Phathom制药(PHAT)$
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
PCAB
PHAT FDA accepts NDA for VOQUEZNA for the treatment of heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD).
PDUFA 07/19/24$Phathom制药(PHAT)$